Literature DB >> 10906764

Identification of the increased expression of monocyte chemoattractant protein-1, cathepsin S, UPIX-1, and other genes in dystrophin-deficient mouse muscles by suppression subtractive hybridization.

J Fang1, G P Shi, P L Vaghy.   

Abstract

The lack of dystrophin results in muscular dystrophy characterized by degeneration, inflammation, and partial regeneration of skeletal muscles. The fate of these muscles may be determined by the extent of adaptation to the defect and the efficiency of regeneration that is affected by inflammatory cells. We have used suppression subtractive hybridization and quantitative Northern blot analysis to identify differentially expressed genes. Increased expression of murine monocyte chemoattractant protein-1 (JE/MCP-1), cathepsin S, UPIX-1, nmb, cathepsin B, and lysozyme M mRNAs were identified in 2-month-old mdx mouse leg muscles. UPIX-1 is a novel gene. Although it was not expressed in control muscles, it was expressed in control brain, heart, and spleen. JE/MCP-1 and cathepsin S proteins in mdx muscles, as well as JE/MCP-1 protein in the serum of mdx mice were also detected. JE/MCP-1 may be responsible for attraction of inflammatory cells, and cathepsin S, a potent elastolytic protease, may contribute to the remodeling of the extracellular matrix that is required for the migration of these cells to the injured muscles. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906764     DOI: 10.1002/1097-4644(2000)79:1<164::aid-jcb10>3.0.co;2-d

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.

Authors:  Ana Babic; Michael H Rosenthal; Gloria M Petersen; Brian M Wolpin; William R Bamlet; Naoki Takahashi; Motokazu Sugimoto; Laura V Danai; Vicente Morales-Oyarvide; Natalia Khalaf; Richard F Dunne; Lauren K Brais; Marisa W Welch; Caitlin L Zellers; Courtney Dennis; Nader Rifai; Carla M Prado; Bette Caan; Tilak K Sundaresan; Jeffrey A Meyerhardt; Matthew H Kulke; Clary B Clish; Kimmie Ng; Matthew G Vander Heiden
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-18       Impact factor: 4.254

2.  Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.

Authors:  Andoria Tjondrokoesoemo; Tobias G Schips; Michelle A Sargent; Davy Vanhoutte; Onur Kanisicak; Vikram Prasad; Suh-Chin J Lin; Marjorie Maillet; Jeffery D Molkentin
Journal:  J Biol Chem       Date:  2016-03-10       Impact factor: 5.157

3.  cDNA suppression subtraction library for screening down-regulated genes in gastric carcinoma.

Authors:  Jian-Jun Du; Ke-Feng Dou; Shu-You Peng; Hua-Sheng Xiao; Wei-Zhong Wang; Wen-Xian Guan; Zhong-Hua Wang; Zhi-Qing Gao; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

4.  Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice.

Authors:  Andoria Tjondrokoesoemo; Tobias Schips; Onur Kanisicak; Michelle A Sargent; Jeffery D Molkentin
Journal:  Hum Mol Genet       Date:  2016-01-06       Impact factor: 6.150

5.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

6.  CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production.

Authors:  Ludovic Arnold; Hélène Perrin; Camille Baudesson de Chanville; Marielle Saclier; Patricia Hermand; Lucie Poupel; Elodie Guyon; Fabrice Licata; Wassila Carpentier; José Vilar; Rémi Mounier; Bénédicte Chazaud; Nora Benhabiles; Alexandre Boissonnas; Béhazine Combadiere; Christophe Combadiere
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.